The emerging treatment of this peptide represents a exciting development in the management of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide251684.atualblog.com/48720832/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment